SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-059949
Filing Date
2017-11-17
Accepted
2017-11-17 16:16:07
Documents
3
Period of Report
2017-12-07
Effectiveness Date
2017-11-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv479798_def14a.htm DEF 14A 130510
2 GRAPHIC tv479798_img01.jpg GRAPHIC 252324
3 GRAPHIC tv479798_img02.jpg GRAPHIC 205279
  Complete submission text file 0001144204-17-059949.txt   762213
Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (858) 909-0749
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-31326 | Film No.: 171211145
SIC: 8731 Services-Commercial Physical & Biological Research